Wetzel Investment Advisors, Inc. Astrazeneca PLC Transaction History
Wetzel Investment Advisors, Inc.
- $176 Million
- Q1 2024
A detailed history of Wetzel Investment Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 319 shares of AZN stock, worth $24,923. This represents 0.01% of its overall portfolio holdings.
Number of Shares
319
Previous 319
-0.0%
Holding current value
$24,923
Previous $21,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,280Shares Held
483MCall Options Held
5.99MPut Options Held
5.22M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.79 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.84 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.36 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.7 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...